Access cutting-edge rhabdomyosarcoma treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access rhabdomyosarcoma specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rhabdomyosarcoma treatment provided free
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-
Sponsor: Children's Oncology Group
Check if you qualify for this rhabdomyosarcoma clinical trial in Phoenix, AZ
If you're searching for rhabdomyosarcoma treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rhabdomyosarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.